Electromed Inc (ELMD) FinancialsELMDFinancialElectromed Inc

Electromed Inc (ELMD) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Home Care-Commercial, accounting for 44.1% of total sales, equivalent to $8.19M. Other significant revenue streams include Home Care-Medicare and Homecare-Medicare Supplemental. Understanding this composition is critical for investors evaluating how ELMD navigates market cycles within the Advanced Medical Equipment & Technology industry.

Evaluating the bottom line, Electromed Inc maintains a gross margin of 78.71%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 19.70%, while the net margin is 17.52%. These profitability ratios, combined with a Return on Equity (ROE) of 23.26%, provide a clear picture of how effectively ELMD converts its operational activities into shareholder value.

In the context of the broader market, ELMD competes directly with industry leaders such as OSUR and LAB. With a market capitalization of $341.30M, it holds a leading position in the sector. When comparing efficiency, ELMD's gross margin of 78.71% stands against OSUR's 43.46% and LAB's 52.40%. Such benchmarking helps identify whether Electromed Inc is trading at a premium or discount relative to its financial performance.

Electromed has shown consistent revenue growth, with Q3 2026 revenues of $18.6 million, an 18.4% year-over-year increase. The company has achieved 14 consecutive quarters of revenue and profit growth, with a net income of $3.4 million in Q4 2026, reflecting strong operational performance.